Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 39Pancreatic Neoplasms 19Stomach Neoplasms 13Colonic Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Adenocarcinoma Of Esophagus 11Rectal Neoplasms 10Neoplasm Metastasis 10Burkitt Lymphoma 10Neoplasms 9Esophageal Neoplasms 9Cholangiocarcinoma 6Adenocarcinoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lung Neoplasms 4Leukemia, Biphenotypic, Acute 4Esophageal Squamous Cell Carcinoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Ovarian Neoplasms 3Gallbladder Neoplasms 3Endometrial Neoplasms 3Advanced Solid Tumors 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Lymphoma 2Gastrointestinal Neoplasms 2Down Syndrome 2Carcinoma, Renal Cell 2

Interventions

Specimen Handling 3Biopsy 3Endoscopy, Gastrointestinal 2trifluridine tipiracil drug combination 1obeticholic acid 1Thiamine 1Sirolimus 1Sigmoidoscopy 1Oxaliplatin 1Nivolumab 1Leucovorin 1Gastroscopy 1Fluorouracil 1Exercise Therapy 1Endoscopy, Digestive System 1Colonoscopy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenomatous Polyposis Coli × Leucovorin × 90 days × Clear all
NCT05919264 2026-05-28

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Parabilis Medicines, Inc.

Phase 1/2 Recruiting
595 enrolled
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡